BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11799125)

  • 1. Unconventional potentiation of gene expression by Ikaros.
    Koipally J; Heller EJ; Seavitt JR; Georgopoulos K
    J Biol Chem; 2002 Apr; 277(15):13007-15. PubMed ID: 11799125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding.
    Cobb BS; Morales-Alcelay S; Kleiger G; Brown KE; Fisher AG; Smale ST
    Genes Dev; 2000 Sep; 14(17):2146-60. PubMed ID: 10970879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.
    Kim J; Sif S; Jones B; Jackson A; Koipally J; Heller E; Winandy S; Viel A; Sawyer A; Ikeda T; Kingston R; Georgopoulos K
    Immunity; 1999 Mar; 10(3):345-55. PubMed ID: 10204490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms.
    Ronni T; Payne KJ; Ho S; Bradley MN; Dorsam G; Dovat S
    J Biol Chem; 2007 Jan; 282(4):2538-47. PubMed ID: 17135265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis.
    Zhang J; Jackson AF; Naito T; Dose M; Seavitt J; Liu F; Heller EJ; Kashiwagi M; Yoshida T; Gounari F; Petrie HT; Georgopoulos K
    Nat Immunol; 2011 Nov; 13(1):86-94. PubMed ID: 22080921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin restriction by the nucleosome remodeler Mi-2β and functional interplay with lineage-specific transcription regulators control B-cell differentiation.
    Yoshida T; Hu Y; Zhang Z; Emmanuel AO; Galani K; Muhire B; Snippert HJ; Williams CJ; Tolstorukov MY; Gounari F; Georgopoulos K
    Genes Dev; 2019 Jul; 33(13-14):763-781. PubMed ID: 31123064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors.
    Kelley CM; Ikeda T; Koipally J; Avitahl N; Wu L; Georgopoulos K; Morgan BA
    Curr Biol; 1998 Apr; 8(9):508-15. PubMed ID: 9560339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation.
    Gurel Z; Ronni T; Ho S; Kuchar J; Payne KJ; Turk CW; Dovat S
    J Biol Chem; 2008 Mar; 283(13):8291-300. PubMed ID: 18223295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic interactions between Ikaros and the chromatin remodeler Mi-2beta determine silencer activity and Cd4 gene expression.
    Naito T; Gómez-Del Arco P; Williams CJ; Georgopoulos K
    Immunity; 2007 Nov; 27(5):723-34. PubMed ID: 17980631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator.
    Trinh LA; Ferrini R; Cobb BS; Weinmann AS; Hahm K; Ernst P; Garraway IP; Merkenschlager M; Smale ST
    Genes Dev; 2001 Jul; 15(14):1817-32. PubMed ID: 11459831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IKAROS interaction with a complex including chromatin remodeling and transcription elongation activities is required for hematopoiesis.
    Bottardi S; Mavoungou L; Pak H; Daou S; Bourgoin V; Lakehal YA; Affar el B; Milot E
    PLoS Genet; 2014 Dec; 10(12):e1004827. PubMed ID: 25474253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1.
    Popescu M; Gurel Z; Ronni T; Song C; Hung KY; Payne KJ; Dovat S
    J Biol Chem; 2009 May; 284(20):13869-13880. PubMed ID: 19282287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.
    Sabbattini P; Lundgren M; Georgiou A; Chow C; Warnes G; Dillon N
    EMBO J; 2001 Jun; 20(11):2812-22. PubMed ID: 11387214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ikaros, CK2 kinase, and the road to leukemia.
    Dovat S; Song C; Payne KJ; Li Z
    Mol Cell Biochem; 2011 Oct; 356(1-2):201-7. PubMed ID: 21750978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development.
    Sun L; Liu A; Georgopoulos K
    EMBO J; 1996 Oct; 15(19):5358-69. PubMed ID: 8895580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of lymphocyte development by the Ikaros gene family.
    Cortes M; Wong E; Koipally J; Georgopoulos K
    Curr Opin Immunol; 1999 Apr; 11(2):167-71. PubMed ID: 10322160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes.
    Sridharan R; Smale ST
    J Biol Chem; 2007 Oct; 282(41):30227-38. PubMed ID: 17681952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility.
    Ezzat S; Yu S; Asa SL
    Mol Endocrinol; 2005 Apr; 19(4):1004-11. PubMed ID: 15618287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aiolos and Ikaros: regulators of lymphocyte development, homeostasis and lymphoproliferation.
    Schmitt C; Tonnelle C; Dalloul A; Chabannon C; Debré P; Rebollo A
    Apoptosis; 2002 Jun; 7(3):277-84. PubMed ID: 11997672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.
    Koipally J; Renold A; Kim J; Georgopoulos K
    EMBO J; 1999 Jun; 18(11):3090-100. PubMed ID: 10357820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.